{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T05:49:45Z","timestamp":1770788985628,"version":"3.50.0"},"reference-count":122,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>\n                      Irving M. Ariel, MD, a pathologist at Mount Sinai Hospital in New York, published an article on small bowel neuroendocrine tumor (SB-NET) in the\n                      <jats:italic>Archives of Pathology<\/jats:italic>\n                      in 1939 titled \u201cArgentaffin (Carcinoid) Tumors of the Small Intestine: Report of 11 Cases and Review of Literature,\u201d wherein he documented 11 cases of neuroendocrine tumors. SB-NET has since evolved in all aspects from terminology to treatment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To review the current literature on SB-NET to study the new breakthroughs of these tumors with reference to Dr Ariel\u2019s 1939 paper.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Data Sources.\u2014<\/jats:title>\n                    <jats:p>The literature was reviewed to study the recent advances of SB-NET.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>We found that Dr Ariel\u2019s paper stood the test of time even with all the modern innovations in the pathophysiology of SB-NET.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2025-0243-ra","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T21:28:18Z","timestamp":1766438898000},"page":"19-26","source":"Crossref","is-referenced-by-count":0,"title":["Small Bowel Neuroendocrine Tumors: An Update"],"prefix":"10.5858","volume":"150","author":[{"given":"Deepika","family":"Savant","sequence":"first","affiliation":[{"name":"From the Department of Anatomic Pathology, Zucker School of Medicine at Hofstra\/Northwell, Greenvale, New York (Savant)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mamoun","family":"Younes","sequence":"additional","affiliation":[{"name":"the Department of Pathology, George Washington University School of Medicine and Health Sciences, Washington, DC (Younes)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","reference":[{"issue":"1","key":"i1543-2165-150-1-19-b01","series-title":"Am Soc Clin Oncol Educ Book","first-page":"92","article-title":"The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap","volume":"35","author":"Klimstra","year":"2015","unstructured":"Klimstra DS,\nBeltran H,\nLilenbaum R,\nBergsland E. The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap. Am Soc Clin Oncol Educ Book. 2015;35(1):92\u2013103."},{"issue":"1","key":"i1543-2165-150-1-19-b02","series-title":"Arch Pathol","first-page":"25","article-title":"Argentaffin (carcinoid) tumors of small intestine: report of 11 cases and review of literature","volume":"27","author":"Ariel","year":"1939","unstructured":"Ariel IM. Argentaffin (carcinoid) tumors of small intestine: report of 11 cases and review of literature. Arch Pathol. 1939;27(1):25\u201352."},{"key":"i1543-2165-150-1-19-b03","series-title":"Frankf Z Pathol","first-page":"426","article-title":"Karzenoide Tumoren des Dunndarms","volume":"1","author":"Oberndorfer","year":"1907","unstructured":"Oberndorfer S. Karzenoide Tumoren des Dunndarms. Frankf Z Pathol. 1907;1:426\u2013439."},{"key":"i1543-2165-150-1-19-b04","series-title":"Am J Surg","first-page":"124","article-title":"Carcinoid tumors of the ileum","volume":"146","author":"Peck","year":"1983","unstructured":"Peck JJ,\nShields AB,\nBoyden AM,\nDworkin LA,\nNadal JW. Carcinoid tumors of the ileum. Am J Surg. 1983;146:124\u2013132."},{"issue":"6","key":"i1543-2165-150-1-19-b05","series-title":"Am J Surg Pathol","first-page":"811","article-title":"Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases","volume":"27","author":"Yantiss","year":"2003","unstructured":"Yantiss RK,\nOdze RD,\nFarraye FA,\nRosenberg AE. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol. 2003;27(6):811\u2013817."},{"key":"i1543-2165-150-1-19-b06","series-title":"Pathologische Anatomie, ein Lehrbuch fur Studierende und Ante","first-page":"831","volume":"2","author":"Aschoff","year":"1911","unstructured":"Aschoff LE. Pathologische Anatomie, ein Lehrbuch fur Studierende und Ante. Vol 2. 3rd ed. Jena, Germany: Gustav Fischer; 1911:831."},{"key":"i1543-2165-150-1-19-b07","series-title":"Am J Pathol","first-page":"181","article-title":"Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa","volume":"4","author":"Masson","year":"1928","unstructured":"Masson P. Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am J Pathol. 1928;4:181\u2013211."},{"issue":"1","key":"i1543-2165-150-1-19-b08","series-title":"Lancet Oncol","first-page":"61","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","unstructured":"Modlin IM,\nOberg K,\nChung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61\u201372."},{"issue":"4","key":"i1543-2165-150-1-19-b09","series-title":"Endocr Relat Cancer","first-page":"1083","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","unstructured":"Pape UF,\nBerndt U,\nM\u00fcller-Nordhorn J, et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2008;15(4):1083\u20131097."},{"key":"i1543-2165-150-1-19-b10","series-title":"World Health Organization International Histological Classification of Tumours","article-title":"Histologic Typing of Endocrine Tumours","author":"Solcia","year":"2000","unstructured":"Solcia E,\nKloppel G,\nSobin LH, et al. Histologic Typing of Endocrine Tumours. 2nd ed. Heidelberg, Germany: Springer Verlag; 2000. World Health Organization International Histological Classification of Tumours."},{"issue":"8","key":"i1543-2165-150-1-19-b11","series-title":"World J Gastrointest Oncol","first-page":"791","article-title":"Gastrointestinal neuroendocrine tumors in 2020","volume":"12","author":"Ahmed","year":"2020","unstructured":"Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol. 2020;12(8):791\u2013807."},{"key":"i1543-2165-150-1-19-b12","series-title":"Digestive System Tumours","first-page":"16","article-title":"Classification of neuroendocrine neoplasms of the digestive system","volume":"1","author":"Klimstra","year":"2019","unstructured":"Klimstra DS,\nKloppel G,\nLa Rosa S, et al. Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumors Editorial Board, ed. Digestive System Tumours. 5th ed. Lyon (France): IARC; 2019:16\u201319. WHO Classification of Tumours; vol 1."},{"key":"i1543-2165-150-1-19-b13","series-title":"Front Oncol","first-page":"1079575","article-title":"Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: a SEER database analysis, 1977\u20132016","volume":"13","author":"Liu","year":"2023","unstructured":"Liu M,\nWei L,\nLiu W, et al. Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: a SEER database analysis, 1977\u20132016. Front Oncol. 2023;13:1079575."},{"issue":"1","key":"i1543-2165-150-1-19-b14","series-title":"Ann Surg","first-page":"117","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","unstructured":"Maggard MA,\nO\u2019Connell JB,\nKo CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117\u2013122."},{"issue":"5","key":"i1543-2165-150-1-19-b15","series-title":"Eur J Cancer Prev","first-page":"475","article-title":"Incidence trend of neuroendocrine tumors and disparities by sex and race\/ethnicity in adults from the United States, 2000\u20132020","volume":"33","author":"Zhu","year":"2004","unstructured":"Zhu Y. Incidence trend of neuroendocrine tumors and disparities by sex and race\/ethnicity in adults from the United States, 2000\u20132020. Eur J Cancer Prev. 2004;33(5), 475\u2013484."},{"issue":"39","key":"i1543-2165-150-1-19-b16","series-title":"World J Gastroenterol","first-page":"5208","article-title":"CTGF, intestinal stellate cells and carcinoid fibrogenesis","volume":"13","author":"Kidd","year":"2007","unstructured":"Kidd M,\nModlin I,\nShapiro M, et al. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol. 2007;13(39):5208\u20135216."},{"issue":"6","key":"i1543-2165-150-1-19-b17","series-title":"Gastroenterology","first-page":"1717","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","unstructured":"Modlin IM,\nKidd M,\nLatich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128(6):1717\u20131751."},{"issue":"4","key":"i1543-2165-150-1-19-b18","series-title":"Cancer","first-page":"934","article-title":"A 5-decade analysis of 13\u2009715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","unstructured":"Modlin IM,\nLye KD,\nKidd M. A 5-decade analysis of 13\u2009715 carcinoid tumors. Cancer. 2003;97(4):934\u2013959."},{"issue":"5","key":"i1543-2165-150-1-19-b19","series-title":"World J Methodol","first-page":"381","article-title":"Diagnosis and management of small bowel neuroendocrine tumors: a state-of-the-art","volume":"12","author":"Gonz\u00e1les-Yovera","year":"2022","unstructured":"Gonz\u00e1les-Yovera JG,\nRoseboom PJ,\nConcepci\u00f3n-Zavaleta M, et al. Diagnosis and management of small bowel neuroendocrine tumors: a state-of-the-art. World J Methodol. 2022;12(5):381\u2013391."},{"key":"i1543-2165-150-1-19-b20","series-title":"Cancer","first-page":"901","article-title":"Life history of the carcinoid tumor of the small intestine","volume":"14","author":"Moertel","year":"1961","unstructured":"Moertel CG,\nSauer W,\nDockerty M,\nBaggenstoss A. Life history of the carcinoid tumor of the small intestine. Cancer. 1961;14:901\u2013912."},{"issue":"1","key":"i1543-2165-150-1-19-b21","series-title":"World J Gastrointest Pathophysiol","first-page":"117","article-title":"Small bowel neuroendocrine tumors: from pathophysiology to clinical approach","volume":"7","author":"Xavier","year":"2016","unstructured":"Xavier S,\nRosa B,\nCotter J. Small bowel neuroendocrine tumors: from pathophysiology to clinical approach. World J Gastrointest Pathophysiol. 2016;7(1):117\u2013124."},{"issue":"3","key":"i1543-2165-150-1-19-b22","series-title":"Surg Pathol Clin","first-page":"377","article-title":"Diagnosis and management of gastrointestinal neuroendocrine neoplasms","volume":"13","author":"Gonzalez","year":"2020","unstructured":"Gonzalez RS. Diagnosis and management of gastrointestinal neuroendocrine neoplasms. Surg Pathol Clin. 2020;13(3):377\u2013397."},{"issue":"7","key":"i1543-2165-150-1-19-b23","series-title":"Am J Surg Pathol","first-page":"1101","article-title":"Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor","volume":"32","author":"Anlauf","year":"2008","unstructured":"Anlauf M,\nEnosawa T,\nHenopp T, et al. Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor. Am J Surg Pathol. 2008;32(7):1101\u20131105."},{"key":"i1543-2165-150-1-19-b24","series-title":"J Mol Med","first-page":"413","article-title":"Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors","volume":"76","author":"Rindi","year":"1998","unstructured":"Rindi G,\nCapella C,\nSolcia E. Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors. J Mol Med. 1998;76:413\u2013420."},{"issue":"1","key":"i1543-2165-150-1-19-b25","series-title":"Endocr Pathol","first-page":"115","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","unstructured":"Rindi G,\nMete O,\nUccella S, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115\u2013154."},{"issue":"11","key":"i1543-2165-150-1-19-b26","series-title":"BMC Cancer","first-page":"187","article-title":"Literature survey on epidemiology and pathology of gangliocytic paraganglioma","author":"Okubo","year":"2011","unstructured":"Okubo Y,\nWakayama M,\nNemoto T, et al. Literature survey on epidemiology and pathology of gangliocytic paraganglioma. BMC Cancer. 2011;(11)187."},{"issue":"6","key":"i1543-2165-150-1-19-b27","series-title":"Langenbecks Arch Surg","first-page":"933","article-title":"Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis","volume":"397","author":"Dumitrascu","year":"2012","unstructured":"Dumitrascu T,\nDima S,\nHerlea V, et al. Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis. Langenbecks Arch Surg. 2012;397(6):933\u2013943."},{"issue":"6","key":"i1543-2165-150-1-19-b28","series-title":"Ann Surg","first-page":"815","article-title":"Prognosis and survival in patients with gastrointestinal tract carcinoid tumors","volume":"229","author":"Shebani","year":"1999","unstructured":"Shebani KO,\nSouba WW,\nFinkelstein DM, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg. 1999;229(6):815\u2013823."},{"key":"i1543-2165-150-1-19-b29","series-title":"Lancet","first-page":"1020","article-title":"A case of primary carcinoma of ileum","volume":"2","author":"Ransom","year":"1890","unstructured":"Ransom WB. A case of primary carcinoma of ileum. Lancet. 1890;2:1020\u20131023."},{"key":"i1543-2165-150-1-19-b30","series-title":"Virchows Arch","first-page":"280","article-title":"Uber den primaren Krebs des Ileum nebst Bemerkungen uber das gleichzeitige Vorkommen von Krebs und Tuberkulose","volume":"111","author":"Lubarsch","year":"1888","unstructured":"Lubarsch O. Uber den primaren Krebs des Ileum nebst Bemerkungen uber das gleichzeitige Vorkommen von Krebs und Tuberkulose. Virchows Arch. 1888;111:280\u2013317."},{"key":"i1543-2165-150-1-19-b31","series-title":"Am J Surg Pathol","first-page":"828","article-title":"Carcinoids of the duodenum: a histologic and immunohistochemical study of 65 tumors","volume":"13","author":"Burke","year":"1989","unstructured":"Burke AP,\nFederspiel BH,\nSobin LH, et al. Carcinoids of the duodenum: a histologic and immunohistochemical study of 65 tumors. Am J Surg Pathol 1989;13:828."},{"issue":"7","key":"i1543-2165-150-1-19-b32","series-title":"Ann Oncol","first-page":"72","article-title":"Gastrointestinal neuroendocrine tumors","volume":"21","author":"\u00d6berg","year":"2010","unstructured":"\u00d6berg KE. Gastrointestinal neuroendocrine tumors. Ann Oncol. 2010;21(7):72\u201380."},{"issue":"2","key":"i1543-2165-150-1-19-b33","series-title":"Am J Roentgenol","first-page":"267","article-title":"Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET\/CT","volume":"211","author":"Sanli","year":"2018","unstructured":"Sanli Y,\nGarg I,\nKandathil A, et al. Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET\/CT. Am J Roentgenol. 2018;211(2):267\u2013277."},{"key":"i1543-2165-150-1-19-b34","series-title":"Hum Pathol","first-page":"8","article-title":"Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you","volume":"96","author":"Bellizzi","year":"2020","unstructured":"Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol. 2020;96:8\u201333."},{"issue":"6","key":"i1543-2165-150-1-19-b35","series-title":"Arch Pathol Lab Med","first-page":"750","article-title":"Neuroendocrine tumors of the luminal gastrointestinal tract","volume":"139","author":"Grin","year":"2015","unstructured":"Grin A,\nStreutker CJ. Neuroendocrine tumors of the luminal gastrointestinal tract. Arch Pathol Lab Med. 2015;139(6):750\u2013756."},{"issue":"6","key":"i1543-2165-150-1-19-b36","series-title":"Am J Clin Pathol","first-page":"811","article-title":"INSM1 is a highly specific marker of neuroendocrine differentiation in primary neoplasms of the gastrointestinal tract, appendix, and pancreas","volume":"153","author":"McHugh","year":"2020","unstructured":"McHugh KE,\nMukhopadhyay S,\nDoxtader EE, et al. INSM1 is a highly specific marker of neuroendocrine differentiation in primary neoplasms of the gastrointestinal tract, appendix, and pancreas. Am J Clin Pathol. 2020;153(6):811\u2013820."},{"key":"i1543-2165-150-1-19-b37","series-title":"Mol Cell Endocrinol","first-page":"106","article-title":"Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14\u2009000 neuroendocrine and non-neuroendocrine tumors","volume":"581","author":"M\u00f6ller","year":"2024","unstructured":"M\u00f6ller K,\nUhlig R,\nGorbokon N, et al. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14\u2009000 neuroendocrine and non-neuroendocrine tumors. Mol Cell Endocrinol. 2024;581:106\u2013112."},{"issue":"4","key":"i1543-2165-150-1-19-b38","series-title":"Am J Clin Pathol","first-page":"579","article-title":"INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","unstructured":"Rosenbaum JN,\nGuo Z,\nBaus RM,\nWerner H,\nRehrauer WM,\nLloyd RV. INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms. Am J Clin Pathol. 2015;144(4):579\u2013591."},{"issue":"5","key":"i1543-2165-150-1-19-b39","series-title":"Mod Pathol","first-page":"744","article-title":"INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma","volume":"31","author":"Yoshida,","year":"2018","unstructured":"Yoshida, A,\nMakise N,\nWakai S,\nKawai A,\nHiraoka N. INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma. Mod Pathol. 2018;31(5), 744\u2013752."},{"issue":"8","key":"i1543-2165-150-1-19-b40","series-title":"Mod Pathol","first-page":"1571","article-title":"INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma","volume":"33","author":"Tsai","year":"2020","unstructured":"Tsai HK,\nHornick JL,\nVivero M. INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma. Mod Pathol. 2020;33(8),1571\u20131580."},{"key":"i1543-2165-150-1-19-b41","series-title":"Biomed Res Int","first-page":"1580410","article-title":"INSM1 expression in mesenchymal tumors and its clinicopathological significance","author":"Zhang","year":"2022","unstructured":"Zhang Q,\nDong Y,\nZhou M, et al. (2022). INSM1 expression in mesenchymal tumors and its clinicopathological significance. Biomed Res Int. 2022, 1580410."},{"key":"i1543-2165-150-1-19-b42","series-title":"Arch Pathol Lab Med","first-page":"1522","article-title":"Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin","volume":"130","author":"Jaffee","year":"2006","unstructured":"Jaffee I,\nRahmani M,\nSenghal M,\nYounes M. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Arch Pathol Lab Med. 2006;130:1522\u20131526."},{"issue":"12","key":"i1543-2165-150-1-19-b43","series-title":"Cancer Cytopathology","first-page":"871","article-title":"Algorithmic approach to neuroendocrine tumors in targeted biopsies: practical applications of immunohistochemical markers","volume":"124","author":"Duan","year":"2016","unstructured":"Duan K,\nMete O. Algorithmic approach to neuroendocrine tumors in targeted biopsies: practical applications of immunohistochemical markers. Cancer Cytopathology. 2016;124(12):871\u2013884."},{"issue":"4","key":"i1543-2165-150-1-19-b44","series-title":"Am J Surg Pathol","first-page":"626","article-title":"Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors","volume":"33","author":"Srivastava","year":"2009","unstructured":"Srivastava A,\nHornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol. 2009;33(4):626\u2013632."},{"key":"i1543-2165-150-1-19-b45","series-title":"Gastroenterology","first-page":"1616","article-title":"Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin","volume":"123","author":"Feurle","year":"2002","unstructured":"Feurle GE,\nAnlauf M,\nHamscher G,\nArnold R,\nKloppel G,\nWeihe E. Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin. Gastroenterology. 2002;123:1616\u20131626."},{"issue":"12","key":"i1543-2165-150-1-19-b46","series-title":"Am J Surg Pathol","first-page":"1761","article-title":"Objective quantification of the Ki-67 Proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods","volume":"36","author":"Tang","year":"2012","unstructured":"Tang LH,\nGonen M,\nHedvat C,\nModlin IM,\nKlimstra DS. Objective quantification of the Ki-67 Proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Am J Surg Pathol. 2012;36(12):1761\u20131770."},{"key":"i1543-2165-150-1-19-b47","series-title":"Mod Pathol","first-page":"686","article-title":"Calculation of the Ki-67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies","volume":"28","author":"Reid","year":"2015","unstructured":"Reid MD,\nBagci P,\nOhike N,et al.. Calculation of the Ki-67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Mod Pathol.2015;28:686\u2013694."},{"issue":"3","key":"i1543-2165-150-1-19-b48","series-title":"Am J Clin Pathol","first-page":"398","article-title":"Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors","volume":"143","author":"Shi","year":"2015","unstructured":"Shi C,\nGonzalez RS,\nZhao Z, et al. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. Am J Clin Pathol. 2015;143(3):398\u2013404."},{"issue":"1","key":"i1543-2165-150-1-19-b49","series-title":"Am J Surg Pathol","first-page":"128","article-title":"Mesenteric tumor deposits in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis","volume":"41","author":"Fata","year":"2017","unstructured":"Fata CR,\nGonzalez RS,\nLiu E, et al. Mesenteric tumor deposits in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis. Am J Surg Pathol. 2017;41(1):128\u2013133."},{"key":"i1543-2165-150-1-19-b50","series-title":"AJCC Cancer Staging Manual Editorial Board. AJCC Cancer Staging Manual","first-page":"375","article-title":"Neuroendocrine tumors of the jejunum and ileum","author":"Woltering","year":"2017","unstructured":"Woltering E,\nBergsland E,\nBeyer DT, et al. Neuroendocrine tumors of the jejunum and ileum. In: AJCC Cancer Staging Manual Editorial Board. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017:375\u2013387."},{"issue":"8","key":"i1543-2165-150-1-19-b51","series-title":"Mod Pathol","first-page":"1079","article-title":"Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors","volume":"18","author":"Wang","year":"2005","unstructured":"Wang GG,\nYao JC,\nWorah S, et al. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors. Mod Pathol. 2005;18(8):1079\u20131087."},{"issue":"3","key":"i1543-2165-150-1-19-b52","series-title":"Endocr Relat Cancer","first-page":"953","article-title":"High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids","volume":"16","author":"Andersson","year":"2009","unstructured":"Andersson E,\nSw\u00e4rd C,\nStenman G,\nAhlman H,\nNilsson O. High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids. Endocr Relat Cancer. 2009;16(3):953\u2013966."},{"issue":"6","key":"i1543-2165-150-1-19-b53","series-title":"J Clin Invest","first-page":"2502","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","author":"Banck","year":"2013","unstructured":"Banck MS,\nKanwar R,\nKulkarni AA, et al. The genomic landscape of small intestine neuroendocrine tumors. J Clin Invest. 2013;123(6):2502\u20132508."},{"issue":"5","key":"i1543-2165-150-1-19-b54","series-title":"J Clin Invest","first-page":"e186702","article-title":"Basic science and translational implications of current knowledge on neuroendocrine tumors","volume":"135","author":"Fernandez-Cuesta","year":"2025","unstructured":"Fernandez-Cuesta L,\nAlcala N,\nMathian E, et al. Basic science and translational implications of current knowledge on neuroendocrine tumors. J Clin Invest. 2025;135(5):e186702."},{"issue":"1","key":"i1543-2165-150-1-19-b55","series-title":"Clin Cancer Res","first-page":"250","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","unstructured":"Karpathakis A,\nDibra H,\nPipinikas C,\nFeber A, et al. Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor. Clin Cancer Res. 2016;22(1):250\u2013258."},{"issue":"suppl 3","key":"i1543-2165-150-1-19-b56","series-title":"Ann Surg Oncol","first-page":"S1428","article-title":"Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors","volume":"22","author":"Crona","year":"2015","unstructured":"Crona J,\nGustavsson T,\nNorl\u00e9n O, et al. Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors. Ann Surg Oncol. 2015;22(suppl 3):S1428\u2013S1435."},{"issue":"2","key":"i1543-2165-150-1-19-b57","series-title":"Endocr Pathol","first-page":"91","article-title":"Molecular classification of gastrointestinal and pancreatic neuroendocrine neoplasms: are we ready for that","volume":"35","author":"Uccella","year":"2024","unstructured":"Uccella S. Molecular classification of gastrointestinal and pancreatic neuroendocrine neoplasms: are we ready for that? Endocr Pathol. 2024;35(2):91\u2013106."},{"issue":"3","key":"i1543-2165-150-1-19-b58","series-title":"Rev Endocr Metab Disord","first-page":"527","article-title":"Classification of neuroendocrine neoplasms: lights and shadows","volume":"22","author":"La Rosa","year":"2021","unstructured":"La Rosa S,\nUccella S. Classification of neuroendocrine neoplasms: lights and shadows. Rev Endocr Metab Disord. 2021;22(3):527\u2013538."},{"issue":"8","key":"i1543-2165-150-1-19-b59","series-title":"Epigenomics","first-page":"1245","article-title":"DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors","volume":"7","author":"How-Kit","year":"2015","unstructured":"How-Kit A,\nDejeux E,\nDousset B, et al. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors. Epigenomics. 2015;7(8):1245\u20131258."},{"issue":"5","key":"i1543-2165-150-1-19-b60","series-title":"World J Gastrointest Endosc","first-page":"267","article-title":"Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms","volume":"14","author":"Canakis","year":"2022","unstructured":"Canakis A,\nLee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc. 2022;14(5):267\u2013290."},{"key":"i1543-2165-150-1-19-b61","series-title":"Ther Adv Endocrinol Metab","first-page":"2042018818804698","article-title":"Current best practice in the management of neuroendocrine tumors","volume":"10","author":"Tsoli","year":"2018","unstructured":"Tsoli M,\nChatzellis E,\nKoumarianou A,\nKolomodi D,\nKaltsas G. Current best practice in the management of neuroendocrine tumors. Ther Adv Endocrinol Metab. 2018;10:2042018818804698."},{"issue":"1","key":"i1543-2165-150-1-19-b01","series-title":"Am Soc Clin Oncol Educ Book","first-page":"92","article-title":"The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap","volume":"35","author":"Klimstra","year":"2015","unstructured":"Klimstra DS,\nBeltran H,\nLilenbaum R,\nBergsland E. The spectrum of neuroendocrine tumors: histologic classification, unique features and areas of overlap. Am Soc Clin Oncol Educ Book. 2015;35(1):92\u2013103."},{"issue":"1","key":"i1543-2165-150-1-19-b02","series-title":"Arch Pathol","first-page":"25","article-title":"Argentaffin (carcinoid) tumors of small intestine: report of 11 cases and review of literature","volume":"27","author":"Ariel","year":"1939","unstructured":"Ariel IM. Argentaffin (carcinoid) tumors of small intestine: report of 11 cases and review of literature. Arch Pathol. 1939;27(1):25\u201352."},{"key":"i1543-2165-150-1-19-b03","series-title":"Frankf Z Pathol","first-page":"426","article-title":"Karzenoide Tumoren des Dunndarms","volume":"1","author":"Oberndorfer","year":"1907","unstructured":"Oberndorfer S. Karzenoide Tumoren des Dunndarms. Frankf Z Pathol. 1907;1:426\u2013439."},{"key":"i1543-2165-150-1-19-b04","series-title":"Am J Surg","first-page":"124","article-title":"Carcinoid tumors of the ileum","volume":"146","author":"Peck","year":"1983","unstructured":"Peck JJ,\nShields AB,\nBoyden AM,\nDworkin LA,\nNadal JW. Carcinoid tumors of the ileum. Am J Surg. 1983;146:124\u2013132."},{"issue":"6","key":"i1543-2165-150-1-19-b05","series-title":"Am J Surg Pathol","first-page":"811","article-title":"Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases","volume":"27","author":"Yantiss","year":"2003","unstructured":"Yantiss RK,\nOdze RD,\nFarraye FA,\nRosenberg AE. Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases. Am J Surg Pathol. 2003;27(6):811\u2013817."},{"key":"i1543-2165-150-1-19-b06","series-title":"Pathologische Anatomie, ein Lehrbuch fur Studierende und Ante","first-page":"831","volume":"2","author":"Aschoff","year":"1911","unstructured":"Aschoff LE. Pathologische Anatomie, ein Lehrbuch fur Studierende und Ante. Vol 2. 3rd ed. Jena, Germany: Gustav Fischer; 1911:831."},{"key":"i1543-2165-150-1-19-b07","series-title":"Am J Pathol","first-page":"181","article-title":"Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa","volume":"4","author":"Masson","year":"1928","unstructured":"Masson P. Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am J Pathol. 1928;4:181\u2013211."},{"issue":"1","key":"i1543-2165-150-1-19-b08","series-title":"Lancet Oncol","first-page":"61","article-title":"Gastroenteropancreatic neuroendocrine tumours","volume":"9","author":"Modlin","year":"2008","unstructured":"Modlin IM,\nOberg K,\nChung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol. 2008;9(1):61\u201372."},{"issue":"4","key":"i1543-2165-150-1-19-b09","series-title":"Endocr Relat Cancer","first-page":"1083","article-title":"Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours","volume":"15","author":"Pape","year":"2008","unstructured":"Pape UF,\nBerndt U,\nM\u00fcller-Nordhorn J, et al. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. Endocr Relat Cancer. 2008;15(4):1083\u20131097."},{"key":"i1543-2165-150-1-19-b10","series-title":"World Health Organization International Histological Classification of Tumours","article-title":"Histologic Typing of Endocrine Tumours","author":"Solcia","year":"2000","unstructured":"Solcia E,\nKloppel G,\nSobin LH, et al. Histologic Typing of Endocrine Tumours. 2nd ed. Heidelberg, Germany: Springer Verlag; 2000. World Health Organization International Histological Classification of Tumours."},{"issue":"8","key":"i1543-2165-150-1-19-b11","series-title":"World J Gastrointest Oncol","first-page":"791","article-title":"Gastrointestinal neuroendocrine tumors in 2020","volume":"12","author":"Ahmed","year":"2020","unstructured":"Ahmed M. Gastrointestinal neuroendocrine tumors in 2020. World J Gastrointest Oncol. 2020;12(8):791\u2013807."},{"key":"i1543-2165-150-1-19-b12","series-title":"Digestive System Tumours","first-page":"16","article-title":"Classification of neuroendocrine neoplasms of the digestive system","volume":"1","author":"Klimstra","year":"2019","unstructured":"Klimstra DS,\nKloppel G,\nLa Rosa S, et al. Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumors Editorial Board, ed. Digestive System Tumours. 5th ed. Lyon (France): IARC; 2019:16\u201319. WHO Classification of Tumours; vol 1."},{"key":"i1543-2165-150-1-19-b13","series-title":"Front Oncol","first-page":"1079575","article-title":"Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: a SEER database analysis, 1977\u20132016","volume":"13","author":"Liu","year":"2023","unstructured":"Liu M,\nWei L,\nLiu W, et al. Trends in incidence and survival in patients with gastrointestinal neuroendocrine tumors: a SEER database analysis, 1977\u20132016. Front Oncol. 2023;13:1079575."},{"issue":"1","key":"i1543-2165-150-1-19-b14","series-title":"Ann Surg","first-page":"117","article-title":"Updated population-based review of carcinoid tumors","volume":"240","author":"Maggard","year":"2004","unstructured":"Maggard MA,\nO\u2019Connell JB,\nKo CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240(1):117\u2013122."},{"issue":"5","key":"i1543-2165-150-1-19-b15","series-title":"Eur J Cancer Prev","first-page":"475","article-title":"Incidence trend of neuroendocrine tumors and disparities by sex and race\/ethnicity in adults from the United States, 2000\u20132020","volume":"33","author":"Zhu","year":"2004","unstructured":"Zhu Y. Incidence trend of neuroendocrine tumors and disparities by sex and race\/ethnicity in adults from the United States, 2000\u20132020. Eur J Cancer Prev. 2004;33(5), 475\u2013484."},{"issue":"39","key":"i1543-2165-150-1-19-b16","series-title":"World J Gastroenterol","first-page":"5208","article-title":"CTGF, intestinal stellate cells and carcinoid fibrogenesis","volume":"13","author":"Kidd","year":"2007","unstructured":"Kidd M,\nModlin I,\nShapiro M, et al. CTGF, intestinal stellate cells and carcinoid fibrogenesis. World J Gastroenterol. 2007;13(39):5208\u20135216."},{"issue":"6","key":"i1543-2165-150-1-19-b17","series-title":"Gastroenterology","first-page":"1717","article-title":"Current status of gastrointestinal carcinoids","volume":"128","author":"Modlin","year":"2005","unstructured":"Modlin IM,\nKidd M,\nLatich I, et al. Current status of gastrointestinal carcinoids. Gastroenterology. 2005;128(6):1717\u20131751."},{"issue":"4","key":"i1543-2165-150-1-19-b18","series-title":"Cancer","first-page":"934","article-title":"A 5-decade analysis of 13\u2009715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","unstructured":"Modlin IM,\nLye KD,\nKidd M. A 5-decade analysis of 13\u2009715 carcinoid tumors. Cancer. 2003;97(4):934\u2013959."},{"issue":"5","key":"i1543-2165-150-1-19-b19","series-title":"World J Methodol","first-page":"381","article-title":"Diagnosis and management of small bowel neuroendocrine tumors: a state-of-the-art","volume":"12","author":"Gonz\u00e1les-Yovera","year":"2022","unstructured":"Gonz\u00e1les-Yovera JG,\nRoseboom PJ,\nConcepci\u00f3n-Zavaleta M, et al. Diagnosis and management of small bowel neuroendocrine tumors: a state-of-the-art. World J Methodol. 2022;12(5):381\u2013391."},{"key":"i1543-2165-150-1-19-b20","series-title":"Cancer","first-page":"901","article-title":"Life history of the carcinoid tumor of the small intestine","volume":"14","author":"Moertel","year":"1961","unstructured":"Moertel CG,\nSauer W,\nDockerty M,\nBaggenstoss A. Life history of the carcinoid tumor of the small intestine. Cancer. 1961;14:901\u2013912."},{"issue":"1","key":"i1543-2165-150-1-19-b21","series-title":"World J Gastrointest Pathophysiol","first-page":"117","article-title":"Small bowel neuroendocrine tumors: from pathophysiology to clinical approach","volume":"7","author":"Xavier","year":"2016","unstructured":"Xavier S,\nRosa B,\nCotter J. Small bowel neuroendocrine tumors: from pathophysiology to clinical approach. World J Gastrointest Pathophysiol. 2016;7(1):117\u2013124."},{"issue":"3","key":"i1543-2165-150-1-19-b22","series-title":"Surg Pathol Clin","first-page":"377","article-title":"Diagnosis and management of gastrointestinal neuroendocrine neoplasms","volume":"13","author":"Gonzalez","year":"2020","unstructured":"Gonzalez RS. Diagnosis and management of gastrointestinal neuroendocrine neoplasms. Surg Pathol Clin. 2020;13(3):377\u2013397."},{"issue":"7","key":"i1543-2165-150-1-19-b23","series-title":"Am J Surg Pathol","first-page":"1101","article-title":"Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor","volume":"32","author":"Anlauf","year":"2008","unstructured":"Anlauf M,\nEnosawa T,\nHenopp T, et al. Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor. Am J Surg Pathol. 2008;32(7):1101\u20131105."},{"key":"i1543-2165-150-1-19-b24","series-title":"J Mol Med","first-page":"413","article-title":"Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors","volume":"76","author":"Rindi","year":"1998","unstructured":"Rindi G,\nCapella C,\nSolcia E. Cell biology, clinicopathological profile, and classification of gastro-enteropancreatic endocrine tumors. J Mol Med. 1998;76:413\u2013420."},{"issue":"1","key":"i1543-2165-150-1-19-b25","series-title":"Endocr Pathol","first-page":"115","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","unstructured":"Rindi G,\nMete O,\nUccella S, et al. Overview of the 2022 WHO classification of neuroendocrine neoplasms. Endocr Pathol. 2022;33(1):115\u2013154."},{"issue":"11","key":"i1543-2165-150-1-19-b26","series-title":"BMC Cancer","first-page":"187","article-title":"Literature survey on epidemiology and pathology of gangliocytic paraganglioma","author":"Okubo","year":"2011","unstructured":"Okubo Y,\nWakayama M,\nNemoto T, et al. Literature survey on epidemiology and pathology of gangliocytic paraganglioma. BMC Cancer. 2011;(11)187."},{"issue":"6","key":"i1543-2165-150-1-19-b27","series-title":"Langenbecks Arch Surg","first-page":"933","article-title":"Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis","volume":"397","author":"Dumitrascu","year":"2012","unstructured":"Dumitrascu T,\nDima S,\nHerlea V, et al. Neuroendocrine tumours of the ampulla of Vater: clinico-pathological features, surgical approach and assessment of prognosis. Langenbecks Arch Surg. 2012;397(6):933\u2013943."},{"issue":"6","key":"i1543-2165-150-1-19-b28","series-title":"Ann Surg","first-page":"815","article-title":"Prognosis and survival in patients with gastrointestinal tract carcinoid tumors","volume":"229","author":"Shebani","year":"1999","unstructured":"Shebani KO,\nSouba WW,\nFinkelstein DM, et al. Prognosis and survival in patients with gastrointestinal tract carcinoid tumors. Ann Surg. 1999;229(6):815\u2013823."},{"key":"i1543-2165-150-1-19-b29","series-title":"Lancet","first-page":"1020","article-title":"A case of primary carcinoma of ileum","volume":"2","author":"Ransom","year":"1890","unstructured":"Ransom WB. A case of primary carcinoma of ileum. Lancet. 1890;2:1020\u20131023."},{"key":"i1543-2165-150-1-19-b30","series-title":"Virchows Arch","first-page":"280","article-title":"Uber den primaren Krebs des Ileum nebst Bemerkungen uber das gleichzeitige Vorkommen von Krebs und Tuberkulose","volume":"111","author":"Lubarsch","year":"1888","unstructured":"Lubarsch O. Uber den primaren Krebs des Ileum nebst Bemerkungen uber das gleichzeitige Vorkommen von Krebs und Tuberkulose. Virchows Arch. 1888;111:280\u2013317."},{"key":"i1543-2165-150-1-19-b31","series-title":"Am J Surg Pathol","first-page":"828","article-title":"Carcinoids of the duodenum: a histologic and immunohistochemical study of 65 tumors","volume":"13","author":"Burke","year":"1989","unstructured":"Burke AP,\nFederspiel BH,\nSobin LH, et al. Carcinoids of the duodenum: a histologic and immunohistochemical study of 65 tumors. Am J Surg Pathol 1989;13:828."},{"issue":"7","key":"i1543-2165-150-1-19-b32","series-title":"Ann Oncol","first-page":"72","article-title":"Gastrointestinal neuroendocrine tumors","volume":"21","author":"\u00d6berg","year":"2010","unstructured":"\u00d6berg KE. Gastrointestinal neuroendocrine tumors. Ann Oncol. 2010;21(7):72\u201380."},{"issue":"2","key":"i1543-2165-150-1-19-b33","series-title":"Am J Roentgenol","first-page":"267","article-title":"Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET\/CT","volume":"211","author":"Sanli","year":"2018","unstructured":"Sanli Y,\nGarg I,\nKandathil A, et al. Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET\/CT. Am J Roentgenol. 2018;211(2):267\u2013277."},{"key":"i1543-2165-150-1-19-b34","series-title":"Hum Pathol","first-page":"8","article-title":"Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you","volume":"96","author":"Bellizzi","year":"2020","unstructured":"Bellizzi AM. Immunohistochemistry in the diagnosis and classification of neuroendocrine neoplasms: what can brown do for you? Hum Pathol. 2020;96:8\u201333."},{"issue":"6","key":"i1543-2165-150-1-19-b35","series-title":"Arch Pathol Lab Med","first-page":"750","article-title":"Neuroendocrine tumors of the luminal gastrointestinal tract","volume":"139","author":"Grin","year":"2015","unstructured":"Grin A,\nStreutker CJ. Neuroendocrine tumors of the luminal gastrointestinal tract. Arch Pathol Lab Med. 2015;139(6):750\u2013756."},{"issue":"6","key":"i1543-2165-150-1-19-b36","series-title":"Am J Clin Pathol","first-page":"811","article-title":"INSM1 is a highly specific marker of neuroendocrine differentiation in primary neoplasms of the gastrointestinal tract, appendix, and pancreas","volume":"153","author":"McHugh","year":"2020","unstructured":"McHugh KE,\nMukhopadhyay S,\nDoxtader EE, et al. INSM1 is a highly specific marker of neuroendocrine differentiation in primary neoplasms of the gastrointestinal tract, appendix, and pancreas. Am J Clin Pathol. 2020;153(6):811\u2013820."},{"key":"i1543-2165-150-1-19-b37","series-title":"Mol Cell Endocrinol","first-page":"106","article-title":"Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14\u2009000 neuroendocrine and non-neuroendocrine tumors","volume":"581","author":"M\u00f6ller","year":"2024","unstructured":"M\u00f6ller K,\nUhlig R,\nGorbokon N, et al. Comparison of INSM1 immunostaining with established neuroendocrine markers synaptophysin and chromogranin A in over 14\u2009000 neuroendocrine and non-neuroendocrine tumors. Mol Cell Endocrinol. 2024;581:106\u2013112."},{"issue":"4","key":"i1543-2165-150-1-19-b38","series-title":"Am J Clin Pathol","first-page":"579","article-title":"INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms","volume":"144","author":"Rosenbaum","year":"2015","unstructured":"Rosenbaum JN,\nGuo Z,\nBaus RM,\nWerner H,\nRehrauer WM,\nLloyd RV. INSM1: a novel immunohistochemical and molecular marker for neuroendocrine and neuroepithelial neoplasms. Am J Clin Pathol. 2015;144(4):579\u2013591."},{"issue":"5","key":"i1543-2165-150-1-19-b39","series-title":"Mod Pathol","first-page":"744","article-title":"INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma","volume":"31","author":"Yoshida,","year":"2018","unstructured":"Yoshida, A,\nMakise N,\nWakai S,\nKawai A,\nHiraoka N. INSM1 expression and its diagnostic significance in extraskeletal myxoid chondrosarcoma. Mod Pathol. 2018;31(5), 744\u2013752."},{"issue":"8","key":"i1543-2165-150-1-19-b40","series-title":"Mod Pathol","first-page":"1571","article-title":"INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma","volume":"33","author":"Tsai","year":"2020","unstructured":"Tsai HK,\nHornick JL,\nVivero M. INSM1 expression in a subset of thoracic malignancies and small round cell tumors: rare potential pitfalls for small cell carcinoma. Mod Pathol. 2020;33(8),1571\u20131580."},{"key":"i1543-2165-150-1-19-b41","series-title":"Biomed Res Int","first-page":"1580410","article-title":"INSM1 expression in mesenchymal tumors and its clinicopathological significance","author":"Zhang","year":"2022","unstructured":"Zhang Q,\nDong Y,\nZhou M, et al. (2022). INSM1 expression in mesenchymal tumors and its clinicopathological significance. Biomed Res Int. 2022, 1580410."},{"key":"i1543-2165-150-1-19-b42","series-title":"Arch Pathol Lab Med","first-page":"1522","article-title":"Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin","volume":"130","author":"Jaffee","year":"2006","unstructured":"Jaffee I,\nRahmani M,\nSenghal M,\nYounes M. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Arch Pathol Lab Med. 2006;130:1522\u20131526."},{"issue":"12","key":"i1543-2165-150-1-19-b43","series-title":"Cancer Cytopathology","first-page":"871","article-title":"Algorithmic approach to neuroendocrine tumors in targeted biopsies: practical applications of immunohistochemical markers","volume":"124","author":"Duan","year":"2016","unstructured":"Duan K,\nMete O. Algorithmic approach to neuroendocrine tumors in targeted biopsies: practical applications of immunohistochemical markers. Cancer Cytopathology. 2016;124(12):871\u2013884."},{"issue":"4","key":"i1543-2165-150-1-19-b44","series-title":"Am J Surg Pathol","first-page":"626","article-title":"Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors","volume":"33","author":"Srivastava","year":"2009","unstructured":"Srivastava A,\nHornick JL. Immunohistochemical staining for CDX-2, PDX-1, NESP-55, and TTF-1 can help distinguish gastrointestinal carcinoid tumors from pancreatic endocrine and pulmonary carcinoid tumors. Am J Surg Pathol. 2009;33(4):626\u2013632."},{"key":"i1543-2165-150-1-19-b45","series-title":"Gastroenterology","first-page":"1616","article-title":"Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin","volume":"123","author":"Feurle","year":"2002","unstructured":"Feurle GE,\nAnlauf M,\nHamscher G,\nArnold R,\nKloppel G,\nWeihe E. Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of duodenal origin. Gastroenterology. 2002;123:1616\u20131626."},{"issue":"12","key":"i1543-2165-150-1-19-b46","series-title":"Am J Surg Pathol","first-page":"1761","article-title":"Objective quantification of the Ki-67 Proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods","volume":"36","author":"Tang","year":"2012","unstructured":"Tang LH,\nGonen M,\nHedvat C,\nModlin IM,\nKlimstra DS. Objective quantification of the Ki-67 Proliferative index in neuroendocrine tumors of the gastroenteropancreatic system: a comparison of digital image analysis with manual methods. Am J Surg Pathol. 2012;36(12):1761\u20131770."},{"key":"i1543-2165-150-1-19-b47","series-title":"Mod Pathol","first-page":"686","article-title":"Calculation of the Ki-67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies","volume":"28","author":"Reid","year":"2015","unstructured":"Reid MD,\nBagci P,\nOhike N,et al.. Calculation of the Ki-67 index in pancreatic neuroendocrine tumors: a comparative analysis of four counting methodologies. Mod Pathol.2015;28:686\u2013694."},{"issue":"3","key":"i1543-2165-150-1-19-b48","series-title":"Am J Clin Pathol","first-page":"398","article-title":"Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors","volume":"143","author":"Shi","year":"2015","unstructured":"Shi C,\nGonzalez RS,\nZhao Z, et al. Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumors. Am J Clin Pathol. 2015;143(3):398\u2013404."},{"issue":"1","key":"i1543-2165-150-1-19-b49","series-title":"Am J Surg Pathol","first-page":"128","article-title":"Mesenteric tumor deposits in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis","volume":"41","author":"Fata","year":"2017","unstructured":"Fata CR,\nGonzalez RS,\nLiu E, et al. Mesenteric tumor deposits in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis. Am J Surg Pathol. 2017;41(1):128\u2013133."},{"key":"i1543-2165-150-1-19-b50","series-title":"AJCC Cancer Staging Manual Editorial Board. AJCC Cancer Staging Manual","first-page":"375","article-title":"Neuroendocrine tumors of the jejunum and ileum","author":"Woltering","year":"2017","unstructured":"Woltering E,\nBergsland E,\nBeyer DT, et al. Neuroendocrine tumors of the jejunum and ileum. In: AJCC Cancer Staging Manual Editorial Board. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017:375\u2013387."},{"issue":"8","key":"i1543-2165-150-1-19-b51","series-title":"Mod Pathol","first-page":"1079","article-title":"Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors","volume":"18","author":"Wang","year":"2005","unstructured":"Wang GG,\nYao JC,\nWorah S, et al. Comparison of genetic alterations in neuroendocrine tumors: frequent loss of chromosome 18 in ileal carcinoid tumors. Mod Pathol. 2005;18(8):1079\u20131087."},{"issue":"3","key":"i1543-2165-150-1-19-b52","series-title":"Endocr Relat Cancer","first-page":"953","article-title":"High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids","volume":"16","author":"Andersson","year":"2009","unstructured":"Andersson E,\nSw\u00e4rd C,\nStenman G,\nAhlman H,\nNilsson O. High-resolution genomic profiling reveals gain of chromosome 14 as a predictor of poor outcome in ileal carcinoids. Endocr Relat Cancer. 2009;16(3):953\u2013966."},{"issue":"6","key":"i1543-2165-150-1-19-b53","series-title":"J Clin Invest","first-page":"2502","article-title":"The genomic landscape of small intestine neuroendocrine tumors","volume":"123","author":"Banck","year":"2013","unstructured":"Banck MS,\nKanwar R,\nKulkarni AA, et al. The genomic landscape of small intestine neuroendocrine tumors. J Clin Invest. 2013;123(6):2502\u20132508."},{"issue":"5","key":"i1543-2165-150-1-19-b54","series-title":"J Clin Invest","first-page":"e186702","article-title":"Basic science and translational implications of current knowledge on neuroendocrine tumors","volume":"135","author":"Fernandez-Cuesta","year":"2025","unstructured":"Fernandez-Cuesta L,\nAlcala N,\nMathian E, et al. Basic science and translational implications of current knowledge on neuroendocrine tumors. J Clin Invest. 2025;135(5):e186702."},{"issue":"1","key":"i1543-2165-150-1-19-b55","series-title":"Clin Cancer Res","first-page":"250","article-title":"Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor","volume":"22","author":"Karpathakis","year":"2016","unstructured":"Karpathakis A,\nDibra H,\nPipinikas C,\nFeber A, et al. Prognostic impact of novel molecular subtypes of small intestinal neuroendocrine tumor. Clin Cancer Res. 2016;22(1):250\u2013258."},{"issue":"suppl 3","key":"i1543-2165-150-1-19-b56","series-title":"Ann Surg Oncol","first-page":"S1428","article-title":"Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors","volume":"22","author":"Crona","year":"2015","unstructured":"Crona J,\nGustavsson T,\nNorl\u00e9n O, et al. Somatic mutations and genetic heterogeneity at the CDKN1B locus in small intestinal neuroendocrine tumors. Ann Surg Oncol. 2015;22(suppl 3):S1428\u2013S1435."},{"issue":"2","key":"i1543-2165-150-1-19-b57","series-title":"Endocr Pathol","first-page":"91","article-title":"Molecular classification of gastrointestinal and pancreatic neuroendocrine neoplasms: are we ready for that","volume":"35","author":"Uccella","year":"2024","unstructured":"Uccella S. Molecular classification of gastrointestinal and pancreatic neuroendocrine neoplasms: are we ready for that? Endocr Pathol. 2024;35(2):91\u2013106."},{"issue":"3","key":"i1543-2165-150-1-19-b58","series-title":"Rev Endocr Metab Disord","first-page":"527","article-title":"Classification of neuroendocrine neoplasms: lights and shadows","volume":"22","author":"La Rosa","year":"2021","unstructured":"La Rosa S,\nUccella S. Classification of neuroendocrine neoplasms: lights and shadows. Rev Endocr Metab Disord. 2021;22(3):527\u2013538."},{"issue":"8","key":"i1543-2165-150-1-19-b59","series-title":"Epigenomics","first-page":"1245","article-title":"DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors","volume":"7","author":"How-Kit","year":"2015","unstructured":"How-Kit A,\nDejeux E,\nDousset B, et al. DNA methylation profiles distinguish different subtypes of gastroenteropancreatic neuroendocrine tumors. Epigenomics. 2015;7(8):1245\u20131258."},{"issue":"5","key":"i1543-2165-150-1-19-b60","series-title":"World J Gastrointest Endosc","first-page":"267","article-title":"Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms","volume":"14","author":"Canakis","year":"2022","unstructured":"Canakis A,\nLee LS. Current updates and future directions in diagnosis and management of gastroenteropancreatic neuroendocrine neoplasms. World J Gastrointest Endosc. 2022;14(5):267\u2013290."},{"key":"i1543-2165-150-1-19-b61","series-title":"Ther Adv Endocrinol Metab","first-page":"2042018818804698","article-title":"Current best practice in the management of neuroendocrine tumors","volume":"10","author":"Tsoli","year":"2018","unstructured":"Tsoli M,\nChatzellis E,\nKoumarianou A,\nKolomodi D,\nKaltsas G. Current best practice in the management of neuroendocrine tumors. Ther Adv Endocrinol Metab. 2018;10:2042018818804698."}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"link":[{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/1\/article-p19.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/1\/article-p19.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aplm.kglmeridian.com\/downloadpdf\/journals\/arpa\/150\/1\/article-p19.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T01:14:23Z","timestamp":1770772463000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/150\/1\/article-p19.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":122,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.5858\/arpa.2025-0243-ra","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"value":"1543-2165","type":"electronic"},{"value":"0003-9985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}